Exciting Autism Research: Hopeful Breakthroughs for Rett and Dravet Syndromes! | #autism #news #parenting #rett syndrome #dravet syndrome #research #treatment
Explore contenido cautivador y diversas perspectivas en nuestra página Descubrir. Descubra nuevas ideas y participe en conversaciones significativas
Exciting Autism Research: Hopeful Breakthroughs for Rett and Dravet Syndromes! | #autism #news #parenting #rett syndrome #dravet syndrome #research #treatment
Step into Glamour for a Cause: "GOING HOLLYWOOD" Autism Event! | #autism #event #community #families
Exciting Autism Research: Hopeful Breakthroughs for Rett and Dravet Syndromes | #autism #news #parenting #rett syndrome #dravet syndrome #research #treatment
Roll Out the Red Carpet! "Going Hollywood" Autism Event Coming to Alexandria! | #autism #event #community #families
brindha
For Rett syndrome, Trofinetide (Daybue) is the first FDA-approved treatment, improving behavior, communication, mood, breathing, and hand movements. Researchers are also looking into gene replacement therapies as potential cures.
In Dravet syndrome, gene replacement therapy targeting SCN1A has shown promise in mouse models. TAU depletion has also been effective in reducing seizures and improving survival. Zorevunersen has demonstrated sustained seizure reductions and improvements in behavior and cognition in patients. You can find more information on the Emperor study [https://www.emperorstudy.com/].
Eliminar comentario
¿ Seguro que deseas eliminar esté comentario ?